Sei Investments Co. Purchases 36,858 Shares of Humana Inc. (NYSE:HUM)

Sei Investments Co. boosted its position in shares of Humana Inc. (NYSE:HUM) by 44.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 120,344 shares of the insurance provider’s stock after acquiring an additional 36,858 shares during the period. Sei Investments Co.’s holdings in Humana were worth $50,136,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wade G W & Inc. raised its position in shares of Humana by 3.1% during the first quarter. Wade G W & Inc. now owns 775 shares of the insurance provider’s stock valued at $325,000 after buying an additional 23 shares during the last quarter. Lindbrook Capital LLC raised its position in shares of Humana by 12.1% during the first quarter. Lindbrook Capital LLC now owns 231 shares of the insurance provider’s stock valued at $97,000 after buying an additional 25 shares during the last quarter. AdvisorNet Financial Inc raised its position in shares of Humana by 54.5% during the first quarter. AdvisorNet Financial Inc now owns 85 shares of the insurance provider’s stock valued at $36,000 after buying an additional 30 shares during the last quarter. Wedbush Securities Inc. raised its position in shares of Humana by 3.8% during the first quarter. Wedbush Securities Inc. now owns 882 shares of the insurance provider’s stock valued at $370,000 after buying an additional 32 shares during the last quarter. Finally, Parallel Advisors LLC raised its position in shares of Humana by 3.0% during the first quarter. Parallel Advisors LLC now owns 1,125 shares of the insurance provider’s stock valued at $472,000 after buying an additional 33 shares during the last quarter. Institutional investors own 92.11% of the company’s stock.

NYSE HUM opened at $420.96 on Friday. The company has a fifty day moving average price of $437.99. Humana Inc. has a one year low of $365.06 and a one year high of $475.44. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.43. The firm has a market cap of $54.31 billion, a P/E ratio of 14.97, a P/E/G ratio of 1.46 and a beta of 0.88.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 28th. The insurance provider reported $7.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.21 by $0.46. Humana had a return on equity of 19.08% and a net margin of 4.72%. The firm had revenue of $20.67 billion during the quarter, compared to the consensus estimate of $20.42 billion. During the same period last year, the company earned $5.40 EPS. The company’s quarterly revenue was up 9.2% on a year-over-year basis. On average, research analysts predict that Humana Inc. will post 21.64 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, July 30th. Investors of record on Wednesday, June 30th will be issued a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date is Tuesday, June 29th. Humana’s dividend payout ratio (DPR) is 14.93%.

In other news, insider Timothy Alan Wheatley sold 8,508 shares of Humana stock in a transaction dated Monday, May 3rd. The stock was sold at an average price of $450.59, for a total value of $3,833,619.72. Following the completion of the transaction, the insider now owns 11,494 shares in the company, valued at approximately $5,179,081.46. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Christopher H. Hunter sold 5,156 shares of Humana stock in a transaction dated Thursday, April 29th. The shares were sold at an average price of $443.76, for a total value of $2,288,026.56. Following the completion of the transaction, the insider now owns 8,653 shares of the company’s stock, valued at approximately $3,839,855.28. The disclosure for this sale can be found here. Company insiders own 0.40% of the company’s stock.

Several equities research analysts have recently issued reports on the stock. Mizuho lifted their price objective on shares of Humana from $462.00 to $480.00 and gave the company a “buy” rating in a research report on Thursday, April 29th. Zacks Investment Research cut shares of Humana from a “hold” rating to a “sell” rating and set a $447.00 price target on the stock. in a research report on Tuesday, March 30th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell boosted their price target on shares of Humana from $496.00 to $510.00 and gave the stock a “buy” rating in a research report on Thursday, April 29th. Wells Fargo & Company assumed coverage on shares of Humana in a research report on Monday, May 24th. They issued an “equal weight” rating and a $472.00 price target on the stock. Finally, Oppenheimer lifted their price objective on shares of Humana from $460.00 to $480.00 and gave the stock an “outperform” rating in a research note on Thursday, April 29th. One research analyst has rated the stock with a sell rating, four have given a hold rating and ten have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $469.00.

Humana Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Story: What is a Roth IRA?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.